Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis

Wild-type (senile) ATTR amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Wild-type (senile) ATTR amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis
CDC on Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis
Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis in the news
Blogs on Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Wild-type (senile) ATTR amyloidosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Natural History, Complications, and Prognosis

Complications

Common complications associated with ATTR amyloidosis include:

• Central nervous system complications are increasingly noted in liver-transplanted ATTR patients.
• Atrial fibrillation (AF) is a risk factor for ischemic CNS complications observed after liver transplantation.